CV ASC Registry Education-Seq#5033 (New Antiarrhythmic Therapy Initiated Prior to Cath Lab)

Seq#5033 (New Antiarrhythmic Therapy Initiated Prior to Cath Lab)

Video Transcription

Sequence 5033 antiarrhythmic therapy initiated prior to cath lab is indicating if the patient received new antiarrhythmic therapy, defined as initiation of a new drug to the patient  for the purpose of controlling an abnormal rhythm in the last 30 days prior to the procedure. When a patient is experiencing an abnormal rhythm and a medication is given IV push or  bolus such as ACLS drugs like atropine, lidocaine, adenosine, so on and so forth, while they are treating the rhythm acutely, they may not be controlling it for the long term and  those type of medications would not be captured here.

Video Summary

Antiarrhythmic therapy initiated prior to catheterization lab aims to determine if a patient recently started new medication for abnormal heart rhythms. Drugs like atropine and adenosine, administered for acute rhythm treatment, are not considered long-term solutions and are not included in this assessment. The focus is on identifying patients who received a new antiarrhythmic drug within the last 30 days to manage abnormal heart rhythms before the procedure.

Keywords

antiarrhythmic therapy

catheterization lab

medication

abnormal heart rhythms

30 days